SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-253123
Filing Date
2023-10-10
Accepted
2023-10-10 08:04:32
Documents
40
Period of Report
2023-10-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d512932d8k.htm   iXBRL 8-K 62030
2 EX-99.1 d512932dex991.htm EX-99.1 44640
3 EX-99.2 d512932dex992.htm EX-99.2 33767
7 GRAPHIC g512932ex99_2s10g1.jpg GRAPHIC 86943
8 GRAPHIC g512932ex99_2s11g1.jpg GRAPHIC 60151
9 GRAPHIC g512932ex99_2s12g1.jpg GRAPHIC 57873
10 GRAPHIC g512932ex99_2s13g1.jpg GRAPHIC 95961
11 GRAPHIC g512932ex99_2s14g1.jpg GRAPHIC 91188
12 GRAPHIC g512932ex99_2s15g1.jpg GRAPHIC 73943
13 GRAPHIC g512932ex99_2s16g1.jpg GRAPHIC 59615
14 GRAPHIC g512932ex99_2s17g1.jpg GRAPHIC 75990
15 GRAPHIC g512932ex99_2s18g1.jpg GRAPHIC 60920
16 GRAPHIC g512932ex99_2s19g1.jpg GRAPHIC 70653
17 GRAPHIC g512932ex99_2s1g1.jpg GRAPHIC 30396
18 GRAPHIC g512932ex99_2s20g1.jpg GRAPHIC 59986
19 GRAPHIC g512932ex99_2s21g1.jpg GRAPHIC 67463
20 GRAPHIC g512932ex99_2s22g1.jpg GRAPHIC 45087
21 GRAPHIC g512932ex99_2s23g1.jpg GRAPHIC 39781
22 GRAPHIC g512932ex99_2s24g1.jpg GRAPHIC 71592
23 GRAPHIC g512932ex99_2s25g1.jpg GRAPHIC 26907
24 GRAPHIC g512932ex99_2s2g1.jpg GRAPHIC 138412
25 GRAPHIC g512932ex99_2s3g1.jpg GRAPHIC 49369
26 GRAPHIC g512932ex99_2s4g1.jpg GRAPHIC 89400
27 GRAPHIC g512932ex99_2s5g1.jpg GRAPHIC 82932
28 GRAPHIC g512932ex99_2s6g1.jpg GRAPHIC 77671
29 GRAPHIC g512932ex99_2s7g1.jpg GRAPHIC 67795
30 GRAPHIC g512932ex99_2s8g1.jpg GRAPHIC 86829
31 GRAPHIC g512932ex99_2s9g1.jpg GRAPHIC 101052
32 GRAPHIC g512932img01.jpg GRAPHIC 13642
  Complete submission text file 0001193125-23-253123.txt   2738802

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA akro-20231010.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE akro-20231010_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akro-20231010_pre.xml EX-101.PRE 11262
34 EXTRACTED XBRL INSTANCE DOCUMENT d512932d8k_htm.xml XML 3367
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38944 | Film No.: 231315781
SIC: 2834 Pharmaceutical Preparations